Listed by the USPTO as DAVIS, RUTH A
Tech Center 1600 • Art Units: 1645 1651 1653 1699
This examiner grants 61% of resolved cases
Ruth A. Davis has 919 resolved cases in Tech Center 1600 and Art Unit 1645. The allowance rate is 60.9%, with a median of 1169 days to allowance. The large case base supports a moderate allowance assessment, while the median timeline indicates that prosecution typically requires sustained attention.
The interview lift is 31.0%, suggesting that interviews may help focus issues and shape later written responses. The leading companies are DSM IP Assets, Ipsen Biopharm, and Genmont Biotech. Casimir Jones, NIXON & VANDERHYE, and PROSKAUER ROSE are the listed leading firms.
| App # | Title | Status | Assignee |
|---|---|---|---|
| 18872675 | COMBINATIONS COMPRISING VITAMIN C AND LACTOBACILLUS RHAMNOSUS | Non-Final OA | DSM IP Assets B.V. |
| 18834722 | YARROWIA PRODUCTION PROCESS | Non-Final OA | DSM IP ASSETS B.V. |
| 17796487 | A METHOD FOR DETERMINING AN ORDER IN WHICH A FOOD PRODUCT IS CULTURED | Final Rejection | DSM IP ASSETS B.V. |
| 18867205 | MICROORGANISM BELONGING TO GENUS AKKERMANSIA | Non-Final OA | OTSUKA PHARMACEUTICAL CO., LTD. |
| 18035134 | COMPOSITIONS AND METHODS FOR SCREENING PESTICIDES | Final Rejection | Arizona Board of Regents on Behalf of the University of Arizona |
| 18563088 | ANTI-OXIDANT CONTAINING PARTICLES AND METHODS OF USE | Non-Final OA | The United States Government, as Represented by the Department of Veterans Affairs |
| 18836135 | USE OF PROBIOTICS FOR MODULATING ALLERGIC IMMUNE RESPONSES | Non-Final OA | INTERNATIONAL N&H DENMARK APS |
| 18713941 | CORYNEBACTERIUM GLUTAMICUM VARIANT HAVING IMPROVED L-LYSINE PRODUCTION ABILITY AND METHOD FOR PRODUCING L-LYSINE BY USING SAME | Final Rejection | DAESANG CORPORATION |
| 18687533 | ENZYME AGENT FOR TRANSESTERIFICATION, INCLUDING LIPASE AS ACTIVE INGREDIENT | Non-Final OA | AMANO ENZYME INC. |
| 18265076 | ELEVATION OF GLYCOSAMINOGLYCANS IN SUBJECTS WITHOUT MUCOPOLYSACCHARIDOSIS | Final Rejection | THE NEMOURS FOUNDATION |
IP Author analyzes examiner patterns and generates tailored response strategies with the highest chance of allowance.
Build Your Strategy60.9% of resolved applications examined by Ruth A Davis were allowed (919 resolved cases), compared with 49.5% across Art Unit 1645 over the last five years.
This examiner's interview lift is +31.0 percentage points: the difference in allowance rate between resolved applications that had an examiner interview and those that did not.
Applications allowed by Ruth A Davis took 1,169 days on average from filing to allowance.
Ruth A Davis examines applications in Art Unit 1645 in Tech Center 1600 (Biotechnology & Pharmaceuticals).
